Interventional Oncology Market by Procedure (Radiation Therapy [Internal and External Radiation Therapy], Ablation [Cryoablation Therapy, Microwave Ablation Therapy, and Radiofrequency Ablation], Particle Embolization [Drug-Eluting Beads, Radioembolization, Microspheres, and Polyvinyl Alcohol Particles]) - Global Opportunity Analysis and Industry Forecast, 2018-2025

Get 20% Free Customization In This Report

Medical Devices & Supplies	LI_183702	Pages: NA	Jun 2019 \| 1621 Views
Author(s) : NA	Tables: NA	Charts: NA	Formats*:

Interventional oncology procedures comprise diagnosis and treatment of cancer with the help of minimally invasive procedures that are conducted under image guidance. The process utilizes equipment such as x-ray, ultrasound, computed tomography, or magnetic resonance imaging for guidance purposes. The procedures are carried out using guide accessories and instruments, including ablation electrodes, guidewires, biopsy needles, and intravascular catheters that enable the treatment of a tumor situated in remote parts of the body.

Interventional oncology is used to treat primary or metastatic cancer such as liver cancer, kidney cancer, lung cancer, bone cancer, prostate cancer, breast cancer, and pancreatic cancer. Most of these procedures are conducted either in an outpatient setting or needs an overnight stay in the hospital. Due to its minimally invasive nature, the recovery time required is minimal. Some of the popular procedures are pain palliation, intra-arterial therapies, ablative therapies, and neoadjuvant procedures.

The growing demand for minimally invasive therapeutics is the major driving factor for the market growth. These procedures could also be used to treat patients with other related comorbidities and in inoperable patients. The ability of minimally invasive techniques to treat cancerous cells better than alternative cancer treatments such as radiation therapy, surgeries, and systematic chemotherapy has helped the technique gain popularity.

Moreover, healthcare professionals and patients are gradually opting for minimally invasive procedures in the field of interventional oncology due to advantages of using these techniques such as shorter hospital stay, minimal risk of infection, minimal risk of complications, cause less pain, and faster recovery time in comparison to conventional surgeries. These advantages of using minimally invasive procedures will impel the growth of the global interventional oncology market.

The global interventional oncology market is segmented based on procedure and geography. Based on procedure, the market is categorized into radiation therapy, ablation, and particle embolization. Radiation therapy is further bifurcated into internal and external radiation therapy. Ablation is further categorized into cryoablation therapy, microwave ablation therapy, and radiofrequency ablation. Particle embolization is further classified into drug-eluting beads, radioembolization, microspheres, and polyvinyl alcohol particles. Based on geography, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Comprehensive competitive analysis and profiles of major market players such as Boston Scientific, Accuray, Medtronic, AtriCure, Baylis Medical, BTG, Alpinion Medical Systems, Terumo Corporation, AngioDynamics, and Merit Medical have also been provided in this report.

Key Benefits:

This report provides an extensive analysis of the current and emerging market trends and dynamics in the global market.
This report entails a detailed quantitative analysis of the current market and estimations from 2017-2023, which helps identify prevailing market opportunities.
The projections in this report are made by analyzing the current trends and future market potential from 2017 to 2023 in terms of value.
Competitive intelligence helps understand the competitive scenario globally
An in-depth analysis of current research and clinical developments within the market has been provided with key market dynamic factors that help understand the behavior of the market

Interventional Oncology Market Key Segments:

By Procedure

Radiation Therapy
- Internal Radiation Therapy
- External Radiation Therapy
Ablation
- Cryoablation Therapy
- Microwave Ablation Therapy
- Radiofrequency Ablation
Particle Embolization
- Drug-Eluting Beads
- Radioembolization
- Microspheres
- Polyvinyl Alcohol Particles

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Taiwan
- Rest of Asia-Pacific
LAMEA
- Brazil
- Turkey
- Saudi Arabia
- South Africa
- Rest of LAMEA

"Note : The list of companies mentioned in the description is tentative in nature and may change after detailed analysis."

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS

3.4.1. MARKET DYNAMICS
3.4.2. Drivers
3.4.3. Restraints
3.4.4. Opportunities

Chapter: 4 INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. RADIATION THERAPY

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Internal Radiation Therapy
4.2.5. External Radiation Therapy

4.3. ABLATION

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Cryoablation Therapy
4.3.5. Microwave Ablation Therapy
4.3.6. Radiofrequency Ablation

4.4. PARTICLE EMBOLIZATION

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
4.4.4. Drug-Eluting Beads
4.4.5. Radioembolization
4.4.6. Microspheres
4.4.7. Polyvinyl Alcohol Particles

Chapter: 5 INTERVENTIONAL ONCOLOGY MARKET, BY GEOGRAPHY

5.1. OVERVIEW
5.2. NORTH AMERICA

5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast

5.2.3.1. U.S. market size and forecast
5.2.3.2. Canada market size and forecast
5.2.3.3. Mexico market size and forecast

5.2.4. North America Interventional Oncology Market by Procedure

5.3. EUROPE

5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast

5.3.3.1. Germany market size and forecast
5.3.3.2. France market size and forecast
5.3.3.3. UK market size and forecast
5.3.3.4. Italy market size and forecast
5.3.3.5. Spain market size and forecast
5.3.3.6. Rest of Europe market size and forecast

5.3.4. Europe Interventional Oncology Market by Procedure

5.4. ASIA-PACIFIC

5.4.1. Key market trends
5.4.2. Key growth factors and opportunities
5.4.3. Market size and forecast

5.4.3.1. Japan market size and forecast
5.4.3.2. China market size and forecast
5.4.3.3. Australia market size and forecast
5.4.3.4. India market size and forecast
5.4.3.5. South Korea market size and forecast
5.4.3.6. Taiwan market size and forecast
5.4.3.7. Rest of Asia-Pacific market size and forecast

5.4.4. Asia-Pacific Interventional Oncology Market by Procedure

5.5. LAMEA

5.5.1. Key market trends
5.5.2. Key growth factors and opportunities
5.5.3. Market size and forecast

5.5.3.1. Brazil market size and forecast
5.5.3.2. Turkey market size and forecast
5.5.3.3. Saudi Arabia market size and forecast
5.5.3.4. South Africa market size and forecast
5.5.3.5. Rest of LAMEA market size and forecast

5.5.4. LAMEA Interventional Oncology Market by Procedure

Chapter: 6 COMPANY PROFILES

6.1. BOSTON SCIENTIFIC

6.1.1. Operating business segments
6.1.2. Business performance
6.1.3. Key strategic moves and developments

6.2. ACCURAY

6.2.1. Operating business segments
6.2.2. Business performance
6.2.3. Key strategic moves and developments

6.3. MEDTRONIC

6.3.1. Operating business segments
6.3.2. Business performance
6.3.3. Key strategic moves and developments

6.4. ATRICURE

6.4.1. Operating business segments
6.4.2. Business performance
6.4.3. Key strategic moves and developments

6.5. BAYLIS MEDICAL

6.5.1. Operating business segments
6.5.2. Business performance
6.5.3. Key strategic moves and developments

6.6. BTG

6.6.1. Operating business segments
6.6.2. Business performance
6.6.3. Key strategic moves and developments

6.7. ALPINION MEDICAL SYSTEMS

6.7.1. Operating business segments
6.7.2. Business performance
6.7.3. Key strategic moves and developments

6.8. TERUMO CORPORATION

6.8.1. Operating business segments
6.8.2. Business performance
6.8.3. Key strategic moves and developments

6.9. ANGIODYNAMICS

6.9.1. Operating business segments
6.9.2. Business performance
6.9.3. Key strategic moves and developments

6.10. MERIT MEDICAL

6.10.1. Operating business segments
6.10.2. Business performance
6.10.3. Key strategic moves and developments

"Note : The list of companies mentioned in the description is tentative in nature and may change after detailed analysis."

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Shopping Cart is Empty..

Your Shopping Cart Is Empty

Interventional Oncology Market Key Segments:

By Procedure

By Region

PURCHASE OPTIONS

Reach out to us

Request TOC/Sample

Request Customization

Request TOC/Sample

Why Allied Market Research

Infallible Methodology

Analyst Support

Customization

TARGETED MARKET VIEW

Featured Reports

Featured Readings

Get Fresh content delivered

About

Contact Us

Find Help

Get notification about our new releases

Our Products & Services

CONNECT WITH US

Press Media

We Accept